Colin C. Collins

42.4k citations

201 papers · 16.6k indexed · 7 hit papers · h-index 59

Molecular Biology top 0.2%
Genetics top 0.1%
Cancer Research top 0.1%
Pulmonary and Respiratory Medicine top 0.5%
Oncology top 1%

Co-authors: Joe W. Gray Richard Segraves Yuzhuo Wang David Kowbel Donna G. Albertson Stanislav Volik James C. Fuscoe Shanaz H. Dairkee
Topics: Prostate Cancer Treatment and Research (60 papers)Cancer Genomics and Diagnostics (33 papers)Genomic variations and chromosomal abnormalities (31 papers)
Cited by: Cancer Research Genetics Molecular Biology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Nature Genetics
Partner nations: Canada United States United Kingdom

In The Last Decade

Colin C. Collins

194 papers receiving 16.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

1998 1.6k citations Colin C. Collins, Joe W. Gray et al. profile →
Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4.

1988 1.1k citations Colin C. Collins, Joe W. Gray et al. profile →
Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1

1997 928 citations Colin C. Collins et al. profile →
PIK3CA is implicated as an oncogene in ovarian cancer

1999 925 citations Colin C. Collins, Joe W. Gray et al. profile →
Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis

1998 896 citations Colin C. Collins et al. profile →
Chromosome aberrations in solid tumors

2003 578 citations Colin C. Collins, Joe W. Gray et al. profile →
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

2015 367 citations Arun Azad, Stanislav Volik et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Colin C. Collins

Since Specialization

Citations

This map shows the geographic impact of Colin C. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin C. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin C. Collins more than expected).

Fields of papers citing papers by Colin C. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin C. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin C. Collins. The network helps show where Colin C. Collins may publish in the future.

Co-authorship network of co-authors of Colin C. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Colin C. Collins. A scholar is included among the top collaborators of Colin C. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin C. Collins. Colin C. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	scMUSCL: multi-source transfer learning for clustering scRNA-seq data 2025 ·Bioinformatics ·(unknown),(unknown),Yen‐Yi Lin,Colin C. Collins,Martin Ester	0
2	Phenotype prediction from single-cell RNA-seq data using attention-based neural networks 2024 ·Bioinformatics ·(unknown),Yen‐Yi Lin,Nelson K.Y. Wong,Stanislav Volik,(unknown),Colin C. Collins,Martin Ester	8
3	RNF185 Control of COL3A1 Expression Limits Prostate Cancer Migration and Metastatic Potential 2023 ·Molecular Cancer Research ·Benjamin Van Espen,Htoo Zarni Oo,Colin C. Collins,(unknown),Alfredo Molinolo,Kevin Y. Yip,Rabi Murad,Martin Gleave,Ze’ev A. Ronai	5
4	Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer 2020 ·Clinical Cancer Research ·Mannan Nouri,(unknown),Josselin Caradec,Amy A. Lubik,Na Li,(unknown),Ahn R. Lee,Ladan Fazli,Varune Rohan Ramnarine,(unknown),(unknown),Mike Wang,Jane Foo,Martin Gleave,Brett G. Hollier,Colleen C. Nelson,Colin C. Collins,Xuesen Dong,Ralph Buttyan	29
5	Identification of conserved evolutionary trajectories in tumors 2020 ·Bioinformatics ·Ermin Hodzic,Raunak Shrestha,Salem Malikić,Colin C. Collins,Kevin Litchfield,Samra Turajlic,S. Cenk Şahinalp	9
6	AITL: Adversarial Inductive Transfer Learning with input and output space adaptation for pharmacogenomics 2020 ·Bioinformatics ·Hossein Sharifi-Noghabi,(unknown),Olga Zolotareva,Colin C. Collins,Martin Ester	37
7	Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks 2019 ·GigaScience ·Ermin Hodzic,Raunak Shrestha,(unknown),Kuoyuan Cheng,Colin C. Collins,S. Cenk Şahinalp	8
8	MOLI: multi-omics late integration with deep neural networks for drug response prediction 2019 ·Bioinformatics ·Hossein Sharifi-Noghabi,Olga Zolotareva,Colin C. Collins,Martin Ester	248
9	MechRNA: prediction of lncRNA mechanisms from RNA–RNA and RNA–protein interactions 2018 ·Bioinformatics ·Alexander Gawronski,Michaël Uhl,Yajia Zhang,Yen‐Yi Lin,Yashar S. Niknafs,Varune Rohan Ramnarine,Rohit Malik,Felix Y. Feng,Arul M. Chinnaiyan,Colin C. Collins,S. Cenk Şahinalp,Rolf Backofen	43
10	Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer 2018 ·Cancer Research ·Xinpei Ci,Jun Hao,Xin Dong,Stephen Yiu Chuen Choi,Hui Xue,Rebecca Wu,Sifeng Qu,Peter W. Gout,Fang Zhang,Anne Haegert,Ladan Fazli,Francesco Crea,Christopher J. Ong,Amina Zoubeidi,Housheng Hansen He,Martin Gleave,Colin C. Collins,Dong Lin,Yuzhuo Wang	55
11	Mutational Analysis of Gene Fusions Predicts Novel MHC Class I–Restricted T-Cell Epitopes and Immune Signatures in a Subset of Prostate Cancer 2017 ·Clinical Cancer Research ·(unknown),(unknown),Yen‐Yi Lin,Phineas T. Hamilton,(unknown),(unknown),S. Cenk Şahinalp,Colin C. Collins,Faraz Hach,Julian J. Lum	17
12	Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy 2017 ·Clinical Cancer Research ·Himisha Beltran,Alexander W. Wyatt,Edmund C.P. Chedgy,Adam Donoghue,Matti Annala,Evan W. Warner,Kevin Beja,Michael Sigouros,Fan Mo,Ladan Fazli,Colin C. Collins,James A. Eastham,Michael J. Morris,Mary‐Ellen Taplin,Andrea Sboner,Susan Halabi,Martin Gleave	52
13	Computational identification of micro-structural variations and their proteogenomic consequences in cancer 2017 ·Bioinformatics ·(unknown),Alexander Gawronski,Faraz Hach,Sujun Li,Ibrahim Numanagić,Iman Sarrafi,Swati Mishra,Andrew McPherson,Colin C. Collins,Milan Radovich,Haixu Tang,S. Cenk Şahinalp	8
14	The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer 2016 ·Clinical Cancer Research ·Stephen Yiu Chuen Choi,Hui Xue,Rebecca Wu,Ladan Fazli,Dong Lin,Colin C. Collins,Martin Gleave,Peter W. Gout,Yuzhuo Wang	79
15	BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer 2016 ·Clinical Cancer Research ·(unknown),Raunak Shrestha,Hui Xue,Yuwei Wang,Fang Zhang,Dong Lin,Anne Haegert,Rebecca Wu,Xin Dong,Colin C. Collins,Amina Zoubeidi,Martin Gleave,Peter W. Gout,Yuzhuo Wang	25
16	Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancerbreakdown → 2015 ·Clinical Cancer Research ·Arun Azad,Stanislav Volik,Alexander W. Wyatt,Anne Haegert,Stéphane Le Bihan,Robert H. Bell,Shawn Anderson,Brian McConeghy,Robert Shukin,Jenny Bazov,Jack Youngren,Pamela L. Paris,George Thomas,Eric J. Small,Yuzhuo Wang,Martin Gleave,Colin C. Collins,Kim N.	367
17	Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth 2015 ·Clinical Cancer Research ·Yoshiaki Yamamoto,Yohann Loriot,Eliana Beraldi,Fan Zhang,Alexander W. Wyatt,Nader Al Nakouzi,Fan Mo,Tianyuan Zhou,Youngsoo Kim,Brett P. Monia,A. Robert MacLeod,Ladan Fazli,Yuzhuo Wang,Colin C. Collins,Amina Zoubeidi,Martin Gleave	105
18	TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair 2013 ·Clinical Cancer Research ·Alan Dal Pra,Emilie Lalonde,Jenna Sykes,(unknown),Adrian Ishkanian,Alice Meng,(unknown),John R. Srigley,Anthony M. Joshua,György Petrovics,Theodorus van der Kwast,Andrew Evans,Michael Milosevic,Fred Saad,Colin C. Collins,Jeremy A. Squire,Wan L. Lam,Tarek A. Bismar,Paul C. Boutros,Robert G. Bristow	33
19	The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression 2012 ·Cancer Discovery ·Laurie E. Littlepage,Adam S. Adler,Hosein Kouros‐Mehr,Guiqing Huang,Jonathan Chou,Sheryl R. Krig,Obi L. Griffith,James E. Korkola,Kun Qu,Devon A. Lawson,Qing Xue,Mark D. Sternlicht,Gerrit J.P. Dijkgraaf,Paul Yaswen,Hope S. Rugo,Colleen Sweeney,Colin C. Collins,Joe W. Gray,Howard Y. Chang,Zena Werb	54
20	A Group of Genome-Based Biomarkers That Add to a Kattan Nomogram for Predicting Progression in Men with High-Risk Prostate Cancer 2009 ·Clinical Cancer Research ·Pamela L. Paris,Vivian Weinberg,Giancarlo Albo,Ritu Roy,Catherine Burke,Jeffry Simko,Peter R. Carroll,Colin C. Collins	25

About Colin C. Collins

Colin C. Collins is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 201 papers that have together received 16.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (60 papers), Cancer Genomics and Diagnostics (33 papers) and Genomic variations and chromosomal abnormalities (31 papers). The work is most often cited by research in Cancer Research (4.5k citations), Genetics (4.6k citations) and Molecular Biology (10.2k citations). Colin C. Collins has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Joe W. Gray, Richard Segraves, Yuzhuo Wang, David Kowbel, Donna G. Albertson, Stanislav Volik, James C. Fuscoe, Shanaz H. Dairkee, Wen-Lin Kuo and J. E. Landegent. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact